Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 Jun;96:105-110. doi: 10.1016/j.ejca.2018.03.022. Epub 2018 Apr 24.

PMID:
29698932
2.

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 May;94:1-5. doi: 10.1016/j.ejca.2018.01.112. Epub 2018 Mar 20.

PMID:
29502035
3.

Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.

Golan T, Sella T, Margalit O, Amit U, Halpern N, Aderka D, Shacham-Shmueli E, Urban D, Lawrence YR.

J Natl Compr Canc Netw. 2017 Aug;15(8):1022-1027. doi: 10.6004/jnccn.2017.0138.

PMID:
28784864
4.

Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.

Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff RT, Holter S, Gallinger S, Ahn DH, Aderka D, Apurva J, Bekaii-Saab T, Friedman E, Javle M.

Oncologist. 2017 Jul;22(7):804-810. doi: 10.1634/theoncologist.2016-0415. Epub 2017 May 9. Review.

5.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D.

Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.

PMID:
27380959
6.

Resilience and psychosocial adjustment in digestive system cancer.

Gouzman J, Cohen M, Ben-Zur H, Shacham-Shmueli E, Aderka D, Siegelmann-Danieli N, Beny A.

J Clin Psychol Med Settings. 2015 Mar;22(1):1-13. doi: 10.1007/s10880-015-9416-9.

PMID:
25605269
7.

[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].

Berger Y, Zbar AP, Lebedyev A, Levi Y, Nevler A, Aderka D, Golan T, Purim O, Brenner B, Natur M, Gutman M.

Harefuah. 2014 Jun;153(6):315-9, 368. Hebrew.

PMID:
25095601
8.

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.

Golan T, Kanji ZS, Epelbaum R, Devaud N, Dagan E, Holter S, Aderka D, Paluch-Shimon S, Kaufman B, Gershoni-Baruch R, Hedley D, Moore MJ, Friedman E, Gallinger S.

Br J Cancer. 2014 Sep 9;111(6):1132-8. doi: 10.1038/bjc.2014.418. Epub 2014 Jul 29.

9.

[Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue].

Levi Y, Barshack I, Avivi K, Bar-ILan D, Gutman M, Aderka D, Berger R, Yacobi R.

Harefuah. 2013 Jun;152(6):326-9, 369. Hebrew.

PMID:
23885463
10.

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.

Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, Park JO, Sawaki A, Celik I, Götte H, Melezínková H, Moehler M; Arbeitsgemeinschaft Internistische Onkologie and EXPAND Investigators.

Lancet Oncol. 2013 May;14(6):490-9. doi: 10.1016/S1470-2045(13)70102-5. Epub 2013 Apr 15.

PMID:
23594786
11.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A.

Ann Oncol. 2012 Oct;23(10):2479-516.

PMID:
23012255
12.

Laparoscopic resection of rectal cancer.

Rosin D, Lebedyev A, Urban D, Aderka D, Zmora O, Khaikin M, Hoffman A, Shabtai M, Ayalon A.

Isr Med Assoc J. 2011 Aug;13(8):459-62.

PMID:
21910368
13.

Alice in Wonderland syndrome in H1N1 influenza: case report.

Augarten A, Aderka D.

Pediatr Emerg Care. 2011 Feb;27(2):120. doi: 10.1097/PEC.0b013e318209af7a.

PMID:
21293218
14.

Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine?

Shacham-Shmueli E, Beny A, Geva R, Blachar A, Figer A, Aderka D.

J Clin Oncol. 2011 Apr 1;29(10):e262-5. doi: 10.1200/JCO.2010.32.0242. Epub 2011 Jan 10. No abstract available.

PMID:
21220612
15.

Cetuximab in metastatic colorectal cancer.

Wolf I, Golan T, Shani A, Aderka D.

Lancet Oncol. 2010 Apr;11(4):313-4; author reply 314. doi: 10.1016/S1470-2045(10)70019-X. No abstract available.

PMID:
20359660
16.

Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.

Small RM, Lubezky N, Shmueli E, Figer A, Aderka D, Nakache R, Klausner JM, Ben-Haim M.

J Surg Oncol. 2009 Feb 1;99(2):93-8. doi: 10.1002/jso.21207.

PMID:
19065637
17.

Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines.

Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, Ben-Yosef R.

Cancer Invest. 2007 Sep;25(6):411-8.

PMID:
17882652
18.

High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.

Wolf I, Urban D, Pfeffer R, Catane R, Aderka D.

Acta Oncol. 2007;46(4):550-3. No abstract available.

PMID:
17497324
19.

Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R.

Anticancer Res. 2006 Nov-Dec;26(6B):4423-30.

20.

PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.

Goshen E, Davidson T, Aderka D, Zwas ST.

Br J Radiol. 2006 Jul;79(943):572-7.

PMID:
16823061

Supplemental Content

Loading ...
Support Center